<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a01/9773131/fbaf23d015b6/fmed-09-1086473-g0002.jpg"/> </div> <div class="text-side"> <h1>Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus.</h1> <p>Histopathologic examination of the sample obtained by incisional biopsy of the right axillary nodule. (A) H&amp;E stain (20 × magnification), showing innumerous irregularly-shaped tumor cells with nuclear hyperchromasia and prominent nucleoli intermixed within fibroadipose tissue. (B) Immunostaining for S100 (10 × magnification) showing diffuse nuclear and cytoplasmic positivity in all tumor cells. (C) Immunostaining for melan-A (10 × magnification) showing diffuse cytoplasmic positivity in all tumor cells. (D) Immunostaining for PRAME (10 × magnification) showing diffuse nuclear positivity in all tumor cells.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36569151/" target="_blank">36569151</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>